YopM Plague Vaccine Component: Immunogenicity, Protectiveness, and Mode of Action.

Abstract

The plague virulence protein YopM was studied for immunogenicity, protectiveness, importance of its thrombin-binding, and its localization in infected tissue culture. YopM is highly immunogenic in mice, and human convalescent plague sera contain antibodies to YopM. However, YopM is not a good candidate for a subunit vaccine because it is not protective by either active or passive immunization. Further study is merited to determine whether diagnostic probes for Yersinia pestis could be based on yopM. In the cellular response to Y. pestjs infection of naive mice against plague, 0DB T cells were more important than were CD4 T cells, a finding with large implications for the pathogenesis of plague and for future efforts to improve the plague vaccine. Site-directed mutagenesis of yopM yielded mutants with normal thrombin-binding but that were as avirulent as a Y. pestis strain lacking Y6pM altogether, suggesting that thrombin-binding is not YopM's function in the pathogenesis of plague. YopM is mostly targeted into the cytosol of eukaryotic cells when Y. pestis adheres to them. There, YopM traffics in association with a vesicular pathway and enters the nucleus. This raises the possibility that YopM manipulates host gene expression.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 1998
Accession Number
ADA340810

Entities

People

  • Susan C. Straley

Organizations

  • University of Kentucky

Tags

DTIC Thesaurus Topics

  • Biomedical And Dental Materials
  • Blood
  • Blood Coagulation Factors
  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Confocal Microscopy
  • Medical Personnel
  • Polymer Chemistry
  • Polymeric Films
  • Proteins
  • Proteomics
  • Vaccines

Fields of Study

  • Biology

Readers

  • Immunology
  • Molecular Genetics
  • Neurodegenerative Parkinson's Disease and Rickettsial Disease handbook, including the data level of dopamine, BC, neurons, and PD.

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech